Treatment adherence in newly diagnosed type 2 diabetes: patient characteristics and long-term impact of adherence on inpatient care utilization

References

• Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364–1379. doi:10.2337/dc12-0413.
   PubMed Web of Science ®Google Scholar
• ADA. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36(4):1033–1046. doi:10.2337/dc12-2625.
   PubMed Web of Science ®Google Scholar
• CDC. Distribution of First-Listed Diagnoses Among Hospital Discharges with Diabetes as Any-Listed Diagnosis, Adults Aged 18 Years and Older, United States, 2010. 2014 October 1, 2014 [cited 2015 September 1]; Available from: http://www.cdc.gov/diabetes/statistics/hosp/adulttable1.htm.
   Google Scholar
• ADA. Standards of medical care in diabetes–2010. Diabetes Care. 2010;33 Suppl 1: S11–61. doi:10.2337/dc10-S011.
   PubMed Web of Science ®Google Scholar
• Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–412.
   PubMed Web of Science ®Google Scholar
• Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–47. doi:10.1111/j.1524-4733.2007.00213.x.
   PubMed Web of Science ®Google Scholar
• Hong JS, Kang HC. Relationship between oral antihyperglycemic medication adherence and hospitalization, mortality, and healthcare costs in adult ambulatory care patients with type 2 diabetes in South Korea. Med Care. 2011;49(4):378–384. doi:10.1097/MLR.0b013e31820292d1.
   PubMed Web of Science ®Google Scholar
• Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836–1841. doi:10.1001/archinte.166.17.1836.
   PubMed Web of Science ®Google Scholar
• Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care. 2004;27(9):2149–2153.
   PubMed Web of Science ®Google Scholar
• Cheng S-H, Chen -C-C, Tseng C-H. Does medication adherence lead to lower healthcare expenses for patients with diabetes? Am J Manag Care. 2013;19(8):662–670.
   PubMed Web of Science ®Google Scholar
• Egede LE, Gebregziabher M, Dismuke CE, et al. Medication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement. Diabetes Care. 2012;35(12):2533–2539. doi:10.2337/dc12-0572.
   PubMed Web of Science ®Google Scholar
• Currie CJ, Peyrot M, Morgan CL, et al. The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care. 2012;35(6):1279–1284. doi:10.2337/dc11-1277.
   PubMed Web of Science ®Google Scholar
• Jha AK, Aubert RE, Yao J, et al. Greater adherence to diabetes drugs is linked to less hospital use and could save nearly $5 billion annually. Health Aff (Millwood). 2012;31(8):1836–1846. doi:10.1377/hlthaff.2011.1198.
   PubMed Web of Science ®Google Scholar
• Asche C, LaFleur J, Conner C. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther. 2011;33(1):74–109. doi:10.1016/j.clinthera.2011.01.019.
   PubMed Web of Science ®Google Scholar
• Hansen RA, Farley JF, Droege M, et al. A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005. Clin Ther. 2010;32(7):1308–1319. doi:10.1016/j.clinthera.2010.07.011.
   PubMed Web of Science ®Google Scholar
• Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521–530.
   PubMed Web of Science ®Google Scholar
• Balkrishnan R, Rajagopalan R, Camacho FT, et al. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 2003;25(11):2958–2971.
   PubMed Web of Science ®Google Scholar
• Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25(6):1015–1021.
   PubMed Web of Science ®Google Scholar
• Stuart BC, Simoni-Wastila L, Zhao L, et al. Increased persistency in medication use by U.S. Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings. Diabetes Care. 2009;32(4):647–649. doi:10.2337/dc08-1311.
   PubMed Web of Science ®Google Scholar
• Salas M, Hughes D, Zuluaga A, et al. Costs of medication nonadherence in patients with diabetes mellitus: a systematic review and critical analysis of the literature. Value Health. 2009;12(6):915–922. doi:10.1111/j.1524-4733.2009.00539.x.
   PubMed Web of Science ®Google Scholar
• Egede LE, Gebregziabher M, Echols C, et al. Longitudinal effects of medication nonadherence on glycemic control. Ann Pharmacother. 2014;48(5):562–570. doi:10.1177/1060028014526362.
   PubMed Web of Science ®Google Scholar
• Pladevall M, Williams LK, Potts LA, et al. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care. 2004;27(12):2800–2805.
   PubMed Web of Science ®Google Scholar
• Voorham J, Haaijer-Ruskamp FM, Wolffenbuttel BH, et al. Initiative to analyze type 2 diabetes treatment, medication adherence affects treatment modifications in patients with type 2 diabetes. Clin Ther. 2011;33(1):121–134. doi:10.1016/j.clinthera.2011.01.024.
   PubMed Web of Science ®Google Scholar
• Grant R, Adams AS, Trinacty CM, et al. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care. 2007;30(4):807–812. doi:10.2337/dc06-2170.
   PubMed Web of Science ®Google Scholar
• Han E, Suh D-C, Lee S-M, et al. The impact of medication adherence on health outcomes for chronic metabolic diseases: a retrospective cohort study. Res Social Adm Pharm. 2014;10(6):e87–98. doi:10.1016/j.sapharm.2014.02.001.
   PubMed Web of Science ®Google Scholar
• Encinosa WE, Bernard D, Dor A. Does prescription drug adherence reduce hospitalizations and costs? The case of diabetes. Adv Health Econ Health Serv Res. 2010;22:151–173.
   PubMedGoogle Scholar
• Hess LM, Raebel MA, Conner DA, et al. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40(7–8):1280–1288. doi:10.1345/aph.1H018.
   PubMed Web of Science ®Google Scholar
• Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50(1):105–116.
   PubMed Web of Science ®Google Scholar
• Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218–1224.
   PubMed Web of Science ®Google Scholar
• Wild H. The economic rationale for adherence in the treatment of type 2 diabetes mellitus. Am J Manag Care. 2012;18(3 Suppl): S43–8.
   PubMedGoogle Scholar
• Roebuck MC. Medical cost offsets from prescription drug utilization among medicare beneficiaries. J Manag Care Spec Pharm. 2014;20(10):994–995.
   PubMed Web of Science ®Google Scholar
• Daousi C, Casson IF, Gill GV, et al. Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors. Postgrad Med J. 2006;82(966):280–284. doi:10.1136/pmj.2005.039032.
   PubMed Web of Science ®Google Scholar
• Zhou X, Ji L, Ran X, et al. Prevalence of obesity and its influence on achievement of cardiometabolic therapeutic goals in Chinese type 2 diabetes patients: an analysis of the nationwide, cross-sectional 3B study. PLoS One. 2016;11(1):e0144179. doi:10.1371/journal.pone.0144179.
   PubMed Web of Science ®Google Scholar
• Bezie Y, Molina M, Hernandez N, et al. Therapeutic compliance: a prospective analysis of various factors involved in the adherence rate in type 2 diabetes. Diabetes Metab. 2006;32(6):611–616. doi:10.1016/S1262-3636(07)70316-6.
   PubMed Web of Science ®Google Scholar
• Kirkman MS, Rowan-Martin MT, Levin R, et al. Determinants of adherence to diabetes medications: findings from a large pharmacy claims database. Diabetes Care. 2015;38(4):604–609. doi:10.2337/dc14-2098.
   PubMed Web of Science ®Google Scholar
• Briesacher BA, Andrade SE, Fouayzi H, et al. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28(4):437–443. doi:10.1592/phco.28.4.437.
   PubMed Web of Science ®Google Scholar
• Lee R, Taira DA. Adherence to oral hypoglycemic agents in Hawaii. Prev Chronic Dis. 2005;2(2):A09.
   PubMedGoogle Scholar
• Oslin DW, Pettinati H, Volpicelli JR. Alcoholism treatment adherence: older age predicts better adherence and drinking outcomes. Am J Geriatr Psychiatry. 2002;10(6):740–747.
   PubMed Web of Science ®Google Scholar
• Cohen MJ, Shaykevich S, Cawthon C, et al. Predictors of medication adherence postdischarge: the impact of patient age, insurance status, and prior adherence. J Hosp Med. 2012;7(6):470–475. doi:10.1002/jhm.1940.
   PubMed Web of Science ®Google Scholar
• Barclay TR, Hinkin CH, Castellon SA, et al. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007;26(1):40–49. doi:10.1037/0278-6133.26.1.40.
   PubMed Web of Science ®Google Scholar
• CBO. Offsetting Effects of Prescription Drug Use on Medicare’s Spending for Medical Services. 2012 [cited 2014 October 1]; Available from: http://www.cbo.gov/sites/default/files/cbofiles/attachments/43741-MedicalOffsets-11-29-12.pdf.
   Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497. doi:10.1056/NEJMra050100.
   PubMed Web of Science ®Google Scholar
• Gerber BS, Cano AI, Caceres ML, et al. A pharmacist and health promoter team to improve medication adherence among Latinos with diabetes. Ann Pharmacother. 2010;44(1):70–79. doi:10.1345/aph.1M389.
   PubMed Web of Science ®Google Scholar
• Pringle JL, Boyer A, Conklin MH, et al. The Pennsylvania Project: pharmacist intervention improved medication adherence and reduced health care costs. Health Aff (Millwood). 2014;33(8):1444–1452. doi:10.1377/hlthaff.2013.1398.
   PubMed Web of Science ®Google Scholar
• Lindenmeyer A, Hearnshaw H, Vermeire E, et al. Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists. J Clin Pharm Ther. 2006;31(5):409–419. doi:10.1111/j.1365-2710.2006.00759.x.
   PubMed Web of Science ®Google Scholar
• Misono AS, Cutrona SL, Choudhry NK, et al. Healthcare information technology interventions to improve cardiovascular and diabetes medication adherence. Am J Manag Care. 2010;16(12 Suppl HIT):SP82–92.
   PubMed Web of Science ®Google Scholar
• Hall RL, Willgoss T, Humphrey LJ, et al. The effect of medical device dose-memory functions on patients’ adherence to treatment, confidence, and disease self-management. Patient Prefer Adherence. 2014;8:775–788. doi:10.2147/PPA.S61248.
   PubMed Web of Science ®Google Scholar
• Vervloet M, Van Dijk L, De Bakker DH, et al. Short- and long-term effects of real-time medication monitoring with short message service (SMS) reminders for missed doses on the refill adherence of people with type 2 diabetes: evidence from a randomized controlled trial. Diabet Med. 2014;31(7):821–828. doi:10.1111/dme.12439.
   PubMed Web of Science ®Google Scholar